High-intensity Statin and Ezetimibe Therapy for Asymptomatic Patients With Positive Coronary Calcium

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 6000 participants.

Also called NCT05845424

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 6,000 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05845424
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05845424. Randomized; no masking; primary purpose treatment. Start 2023-07-03 (actual); primary completion 2029-06-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
High-intensity Statin and Ezetimibe Therapy for Asymptomatic Patients With Positive Coronary Calcium
Acronym
DECISION-CAL
Condition
Coronary Artery Calcification
Condition
Dyslipidemias
Intervention (Drug)
Guideline directed statin therapy
Intervention (Drug)
High intensity statin plus ezetimibe therapy
Lead sponsor
Samsung Medical Center (class: other)

Record details

Record id
cardio:ct-nct05845424
Content hash
a21e901397f41f60d13f44c6bdfd1716f431710e041591e7e82016cfa90800bb